Nanoview Biosciences

company

About

Nanoview Biosciences is developing proprietary products that support research, translation and delivery of precision medicine.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

nanoView Diagnostics Inc. (dba NanoView Biosciences), is developing proprietary products that support research, translation and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Our high-throughput, cost-effective analysis solutions enable life science researchers to better understand the biological role of exosomes and how to utilize them as biomarkers to provide improved insight for how diseases are diagnosed, treated and monitored.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.47M
Nanoview Biosciences has raised a total of $1.47M in funding over 2 rounds. Their latest funding was raised on Aug 16, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 16, 2018 Grant $1.25M 1 National Science Foundation Detail
Jun 12, 2017 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Nanoview Biosciences is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant